Setua, Saini
Thangaraju, Kiruphagaran
Dzieciatkowska, Monika
Wilkerson, Rebecca B.
Nemkov, Travis
Lamb, Derek R.
Tagaya, Yutaka
Boyer, Tori
Rowden, Tobi
Doctor, Allan
D’Alessandro, Angelo
Buehler, Paul W.
Funding for this research was provided by:
National Heart, Lung and Blood Institute (R01HL146442, R01HL149714, R21HL150032, R01HL156526, R01HL159862, R01HL158076, R01HL161004, R01HL162120)
Article History
Received: 8 August 2022
Accepted: 15 December 2022
First Online: 23 December 2022
Competing interests
: AD and TN are founders of Omix Technologies Inc, and AD is scientific advisory board member for Hemanext Inc and Macopharma Inc. The other authors have no competing interests to declare.